Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNTA.L Regulatory News (NTA)

  • There is currently no data for NTA

Form 8.3 - Northacre Plc

17 Jan 2013 16:43

RNS Number : 8307V
Mohamed Abdulsalam Alrafi
17 January 2013
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Mohamed Abdulsalam Alrafi

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Northacre Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

16.01.13

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES/NO No

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

2.5p Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

135,000

0.5

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

135,000

0.5

 

TOTAL:

135,000

0.5

135,000

0.5

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

2.5p Ordinary Shares

 

Sale

7,850,000

96p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

2.5p Ordinary Shares

 

Agreement to sell

135,000 shares

96p

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO Yes

 

 

Date of disclosure:

17 January 2013

Contact name:

Dominic Filleul

Telephone number:

020 7623 2345

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Identity of person whose open positions are being disclosed:

Mohamed Alrafi

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Northacre Plc

 

2. OPTIONS AND DERIVATIVES

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

Agreement to sell 135,000 2.5p Ordinary Shares in Northacre Plc dated 16.01.13 to Spadille Limited subject to such shares being dematerialised into certificated form

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to contracts for differences ("CFDs") or spread bets.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETNKODDABKDADD
Date   Source Headline
27th Dec 201210:18 amRNSForm 8.5 (EPT/RI)Northacre Plc
27th Dec 20127:00 amRNSForm 8 (OPD) Northacre PLC
24th Dec 201210:05 amRNSForm 8.5 (EPT/RI)Northacre Plc
21st Dec 201211:17 amRNSForm 8.3 - Northacre PLC
21st Dec 20129:20 amRNSForm 8.5 (EPT/RI) - Northacre Plc
20th Dec 20123:19 pmRNSStatement re Possible Offer
23rd Nov 20124:23 pmRNSReceipt of £10m Dividend & £1.2m Consortium Relief
9th Nov 20127:00 amRNSInterim Report
21st Sep 20124:19 pmRNSReceipt of £13.56m and update on The Lancasters
6th Sep 201212:30 pmRNSDirector/PDMR Shareholding
24th Jul 20127:00 amRNSFinal Results
30th May 20122:31 pmRNSFunding Update
11th May 20121:42 pmRNSDirector/PDMR Shareholding
4th May 20124:45 pmRNSThe Lancasters Update
19th Apr 20122:24 pmRNSDirectorate Change
17th Apr 20124:03 pmRNSVicarage Gate Project
2nd Apr 201211:32 amRNSDirector/PDMR Shareholding
12th Mar 20122:44 pmRNSDirector/PDMR Shareholding
5th Mar 20124:13 pmRNSDirector/PDMR Shareholding
26th Jan 20127:47 amRNSVicarage Gate Project
23rd Dec 20117:00 amRNSUpdate
28th Nov 201110:20 amRNSInterim Results
28th Oct 201111:03 amRNSFunding Update
29th Jul 20117:00 amRNSFinal Results
1st Jul 20114:09 pmRNSUpdate
30th Jun 20116:02 pmRNSHolding(s) in Company
30th Jun 20116:02 pmRNSHolding(s) in Company
24th Jun 201111:47 amRNSDirectorate Change
17th May 20111:25 pmRNSBoard Change
21st Apr 201111:59 amRNSHolding(s) in Company
19th Apr 201111:17 amRNSHolding(s) in Company
11th Apr 20114:27 pmRNSDirector/PDMR Shareholding
7th Apr 20115:35 pmRNSHolding(s) in Company
6th Apr 20115:10 pmRNSHolding(s) in Company
6th Apr 20117:00 amRNSHolding(s) in Company
28th Mar 20113:52 pmRNSHolding(s) in Company
25th Mar 20114:15 pmRNSHolding(s) in Company
24th Mar 201110:39 amRNSHolding(s) in Company
24th Mar 201110:38 amRNSHolding(s) in Company
9th Mar 20111:03 pmRNSDirectorate Change
21st Feb 20113:57 pmRNSHolding(s) in Company
11th Feb 20113:21 pmRNSTrading Statement
20th Dec 20103:32 pmRNSChange of Adviser's Name
8th Dec 20103:40 pmRNSDirector/PDMR Shareholding
29th Nov 20107:00 amRNSHalf Yearly Report
30th Sep 20103:21 pmRNSHolding(s) in Company
24th Sep 20105:15 pmRNSHolding(s) in Company
13th Aug 20103:59 pmRNSAGM Statement
13th Aug 20103:57 pmRNSHolding(s) in Company
11th Aug 20107:30 amRNSThe Lancasters Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.